Pyrrolo-isoquinoline and tetra-hydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-HT7 receptor
申请人:Wyeth
公开号:US06432974B1
公开(公告)日:2002-08-13
Compounds of the formula
are useful in the treatment of anxiety, depression and related disorders of the central nervous system and other conditions such as schizophrenia, sleep disorders, including instances of circadian rhythm, the treatment of alcohol and drug withdrawal and sexual dysfunction.
该式化合物在焦虑、抑郁和中枢神经系统相关疾病以及其他疾病(如精神分裂症、睡眠障碍、包括昼夜节律紊乱、酒精和药物戒断治疗以及性功能障碍)的治疗中非常有用。